These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12763091)
1. Role of metabotropic glutamate receptor subtype 5 (mGluR5) in the maintenance of cold hypersensitivity following a peripheral mononeuropathy in the rat. Urban MO; Hama AT; Bradbury M; Anderson J; Varney MA; Bristow L Neuropharmacology; 2003 Jun; 44(8):983-93. PubMed ID: 12763091 [TBL] [Abstract][Full Text] [Related]
2. Acute activation of the spinal cord metabotropic glutamate subtype-5 receptor leads to cold hypersensitivity in the rat. Hama AT Neuropharmacology; 2003 Mar; 44(4):423-30. PubMed ID: 12646279 [TBL] [Abstract][Full Text] [Related]
3. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687 [TBL] [Abstract][Full Text] [Related]
5. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. Palazzo E; Luongo L; Bellini G; Guida F; Marabese I; Boccella S; Rossi F; Maione S; de Novellis V CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):148-61. PubMed ID: 22483283 [TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Fisher K; Lefebvre C; Coderre TJ Pharmacol Biochem Behav; 2002 Sep; 73(2):411-8. PubMed ID: 12117596 [TBL] [Abstract][Full Text] [Related]
7. mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Walker K; Reeve A; Bowes M; Winter J; Wotherspoon G; Davis A; Schmid P; Gasparini F; Kuhn R; Urban L Neuropharmacology; 2001; 40(1):10-9. PubMed ID: 11077066 [TBL] [Abstract][Full Text] [Related]
8. Role of central and peripheral mGluR5 receptors in post-operative pain in rats. Zhu CZ; Hsieh G; Ei-Kouhen O; Wilson SG; Mikusa JP; Hollingsworth PR; Chang R; Moreland RB; Brioni J; Decker MW; Honore P Pain; 2005 Mar; 114(1-2):195-202. PubMed ID: 15733645 [TBL] [Abstract][Full Text] [Related]
9. mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo. Gabra BH; Smith FL; Navarro HA; Carroll FI; Dewey WL Brain Res; 2008 Jan; 1187():58-66. PubMed ID: 18022146 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM; Movsesyan VA; Faden AI Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750 [TBL] [Abstract][Full Text] [Related]
11. Enhanced pronociception by amygdaloid group I metabotropic glutamate receptors in nerve-injured animals. Ansah OB; Gonçalves L; Almeida A; Pertovaara A Exp Neurol; 2009 Mar; 216(1):66-74. PubMed ID: 19094988 [TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Chapman AG; Nanan K; Williams M; Meldrum BS Neuropharmacology; 2000 Jul; 39(9):1567-74. PubMed ID: 10854901 [TBL] [Abstract][Full Text] [Related]
14. Activation of spinal group I metabotropic glutamate receptors in rats evokes local glutamate release and spontaneous nociceptive behaviors: effects of 2-methyl-6-(phenylethynyl)-pyridine pretreatment. Lorrain DS; Correa L; Anderson J; Varney M Neurosci Lett; 2002 Jul; 327(3):198-202. PubMed ID: 12113911 [TBL] [Abstract][Full Text] [Related]
15. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730 [TBL] [Abstract][Full Text] [Related]
16. Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil. Urban MO; Coutinho SV; Gebhart GF Pain; 1999 May; 81(1-2):45-55. PubMed ID: 10353492 [TBL] [Abstract][Full Text] [Related]
17. Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5. Parelkar NK; Wang JQ Synapse; 2003 Mar; 47(4):255-61. PubMed ID: 12539198 [TBL] [Abstract][Full Text] [Related]
18. Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain. Xie JD; Chen SR; Pan HL J Biol Chem; 2017 Dec; 292(50):20644-20654. PubMed ID: 29074619 [TBL] [Abstract][Full Text] [Related]
19. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Bao WL; Williams AJ; Faden AI; Tortella FC Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947 [TBL] [Abstract][Full Text] [Related]
20. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]